Minesse (Ethinylestradiol, Gestodene | Lactose Anhydrous)

Ethinylestradiol and Gestodene, the active ingredients in Minesse, are a combined oral contraceptive presented as a tablet for oral use. They prevent pregnancy in women of reproductive age.\n\nGNH India supplies Minesse as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minesse, a combined oral contraceptive, is used to prevent pregnancy by inhibiting ovulation and altering cervical mucus.\n\nContraception: Prevents unintended pregnancy in women of childbearing potential.\nMenstrual cycle regulation: Provides cycle control and reduces menstrual-related symptoms.\nHormonal regulation: Offers stable estrogen‑progestin levels for women requiring hormonal balance.

Minesse may cause a range of adverse reactions.\n\nCommon Side Effects:\n- Nausea or mild gastrointestinal upset\n- Breast tenderness or enlargement\n- Headache or migraine\n- Spotting or breakthrough bleeding\n- Weight fluctuation or fluid retention\n- Mood changes or irritability\n\nSerious or Rare Side Effects:\n- Deep vein thrombosis or pulmonary embolism\n- Hypertension or severe blood pressure elevation\n- Hepatic adenoma or liver dysfunction\n- Severe allergic reaction (anaphylaxis)\n- Visual disturbances or eye pain\n- Stroke or myocardial infarction

Before prescribing Minesse, clinicians should consider several safety measures.\n\nAssess cardiovascular risk: evaluate history of thromboembolic events.\nScreen smoking status: avoid use in women over 35 who smoke.\nCheck liver function: contraindicated in severe hepatic disease.\nReview medication list: identify potential drug interactions.\nStore at ambient temperature: keep in the original pack, protect from moisture.

Minesse can interact with other medicines, affecting its efficacy or safety.\n\nMajor Interactions (Avoid):\n- Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine) may markedly reduce contraceptive effectiveness.\n- Anticoagulants (e.g., warfarin) may increase risk of thrombotic events when combined with hormonal contraception.\n\nModerate Interactions (Monitor Closely):\n- Antifungal agents (e.g., ketoconazole) can raise hormone plasma levels.\n- Anticonvulsants (e.g., phenytoin, phenobarbital) may lower contraceptive efficacy.\n- Herbal supplements such as St. John's wort may diminish hormonal activity.